List of Excipients in API MAFENIDE ACETATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing MAFENIDE ACETATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Rising Pharma Holdings Inc | SULFAMYLON | mafenide acetate | 16571-723 | CETYL ALCOHOL | |
| Rising Pharma Holdings Inc | SULFAMYLON | mafenide acetate | 16571-723 | EDETATE DISODIUM | |
| Rising Pharma Holdings Inc | SULFAMYLON | mafenide acetate | 16571-723 | GLYCERIN | |
| Rising Pharma Holdings Inc | SULFAMYLON | mafenide acetate | 16571-723 | METHYLPARABEN | |
| Rising Pharma Holdings Inc | SULFAMYLON | mafenide acetate | 16571-723 | PEG-8 STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for MAFENIDE ACETATE
Excipient focus: CETYL ALCOHOL
MAFENIDE ACETATE drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | mafenide acetate | 16571-723 |
| Mylan Institutional Inc | mafenide acetate | 51079-623 |
| >Company | >Ingredient | >NDC |
MAFENIDE ACETATE drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
MAFENIDE ACETATE drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | mafenide acetate | 16571-723 |
| Mylan Institutional Inc | mafenide acetate | 51079-623 |
| >Company | >Ingredient | >NDC |
MAFENIDE ACETATE drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
MAFENIDE ACETATE drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | mafenide acetate | 16571-723 |
| Mylan Institutional Inc | mafenide acetate | 51079-623 |
| >Company | >Ingredient | >NDC |
MAFENIDE ACETATE drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
MAFENIDE ACETATE drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | mafenide acetate | 16571-723 |
| Mylan Institutional Inc | mafenide acetate | 51079-623 |
| >Company | >Ingredient | >NDC |
MAFENIDE ACETATE drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PEG-8 STEARATE
MAFENIDE ACETATE drug variants containing PEG-8 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | mafenide acetate | 16571-723 |
| Mylan Institutional Inc | mafenide acetate | 51079-623 |
| >Company | >Ingredient | >NDC |
MAFENIDE ACETATE drug variants not containing PEG-8 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 STEARATE
MAFENIDE ACETATE drug variants containing POLYOXYL 40 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | mafenide acetate | 16571-723 |
| Mylan Institutional Inc | mafenide acetate | 51079-623 |
| >Company | >Ingredient | >NDC |
MAFENIDE ACETATE drug variants not containing POLYOXYL 40 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
MAFENIDE ACETATE drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | mafenide acetate | 16571-723 |
| Mylan Institutional Inc | mafenide acetate | 51079-623 |
| >Company | >Ingredient | >NDC |
MAFENIDE ACETATE drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
MAFENIDE ACETATE drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | mafenide acetate | 16571-723 |
| Mylan Institutional Inc | mafenide acetate | 51079-623 |
| >Company | >Ingredient | >NDC |
MAFENIDE ACETATE drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
MAFENIDE ACETATE drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | mafenide acetate | 16571-723 |
| Mylan Institutional Inc | mafenide acetate | 51079-623 |
| >Company | >Ingredient | >NDC |
MAFENIDE ACETATE drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
MAFENIDE ACETATE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | mafenide acetate | 16571-723 |
| Mylan Institutional Inc | mafenide acetate | 51079-623 |
| >Company | >Ingredient | >NDC |
MAFENIDE ACETATE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
